We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reckitt Benckiser Group Plc | LSE:RB. | London | Ordinary Share | GB00B24CGK77 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6,498.00 | 6,502.00 | 6,506.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/7/2014 07:23 | Highlights: Half Year (HY) unless otherwise stated · LFL net revenue growth +3% (+4% ex RBP) driven by excellent consumer health performance. · Q2 LFL net revenue growth +3% (+4% ex RBP). · Gross margin improvement +60bps to 59.3%. · Continued strong investment in brand equity (BEI) with improved efficiency. · Adjusted operating margin (ex RBP) +40bps to 20.8%. · Continuing operating margin expansion targeted for second half (ex RBP). · Adjusted net income -4% (+7% constant); adjusted diluted EPS of 113.4p (-4%). · Strong free cash flow generation of £729m, a conversion rate of 90% of net income. · The Board declares an interim dividend of 60p per share (2013: 60p). · RB Pharmaceuticals strategic review - pursuing a UK listed de-merger. | skinny | |
04/6/2014 08:55 | There are rumours circulating that there could be an bid in the offing so the brokers might be onto something. | tweeeek | |
03/6/2014 21:36 | Stark reminder when broker upgrades on all time highs are a sure sign to get out, as was recently shown by many stocks. One of the most recent that comes to mind is Asos. Brokers upgraded to silly numbers, then halved within weeks!, from £75 to £40! I'd be very carefull | swipe | |
01/6/2014 11:32 | 30 May 2014 Reckitt Benckiser Group plc Share Repurchase Programme Reckitt Benckiser Group plc ("RB") today announces that it will commence a share repurchase programme of RB's ordinary shares of 10 pence each (the "Ordinary Shares") up to a maximum of 6,000,000 Ordinary Shares representing approximately 0.83% of RB's current issued share capital (the "Programme") to offset the dilutive impact of employee share schemes. RB announces that it has entered into an irrevocable, non-discretionary arrangement with Morgan Stanley Securities Limited ("Morgan Stanley") to enable the purchase of Ordinary Shares during the period running from 2 June 2014 and ending no later than 22 August 2014, therefore running through RB's close period of 1 - 28 July. Any purchase of Ordinary Shares done in relation to this announcement will be carried out on the London Stock Exchange and executed in accordance with the Listing Rules and RB's general authority to make market purchases of Shares. RB will announce any market repurchase of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary Shares purchased under the Programme will be held in treasury. | batman9 | |
26/5/2014 16:06 | Another buy rec yipee usually a good sign to open a short | tweeeek | |
23/5/2014 20:22 | Credit Suisse have reiterated buy and TP of £52.00. | batman9 | |
23/5/2014 15:56 | I see it Turned Out Nice Again, was almost choked to death this one, thanks chevey for telling me to hang on in there. | tweeeek | |
20/5/2014 18:38 | Hang on in there, looks like it's dropping. | chevey | |
16/5/2014 13:26 | Thanks for your concern chevey, kick a man while he's down why don't you. | tweeeek | |
16/5/2014 12:54 | How's the shorts, being pulled down me thinks. | chevey | |
02/5/2014 14:54 | Thank you EssentialInvestor I'll keep that in mind, but Deutsche Bank are off the mark with their TP but they're entitled their disillusioned opinion. | tweeeek | |
02/5/2014 14:21 | Its still a good time to place a short, Its the not the cleverest of notes but their entitled to there opinion, £41 the target here. | tweeeek | |
02/5/2014 14:14 | Tweek, the price was pushed down when it was announced they were in talks to buy Merck's consumer products business, as Bayer were also in the running there was the possibility of overpaying, you got the bounce when RB withdrew. The cash generation is what drives the RB. valuation and you need to account for this when looking at the SP, imv The share price can move around a bit so you may get lucky. | essentialinvestor | |
01/5/2014 11:55 | No I didn't close, I am gutted we got the nice drop first thing but then we got the bounce, It going to drop that there is no doubt about so am still holding and still holding a tiny tiny profit. | tweeeek | |
01/5/2014 10:53 | Tweeeek, I hope you closed this am. | essentialinvestor | |
01/5/2014 10:52 | Deutsche Bank has a buy and TP £60.00. | batman9 | |
30/4/2014 21:24 | Looks good for my short placed on the 15th at 4903 should see this bloated stock tumble to the 4100 mark for starters. | tweeeek | |
16/4/2014 07:34 | Making progress, the currency headwinds seem considerable at present. | spacecake | |
16/4/2014 07:15 | Looks poor to me placed a short yesterday at 4903 so should be interesting to see this over valued bloated stock slide | tweeeek | |
16/4/2014 07:09 | Highlights: Q1 (at constant rates) · Total net revenue growth (ex RBP) of +5% and LFL net revenue growth (ex RBP) of +4%. · Strong performance in ENA against tough comparatives. · Sustained growth in LAPAC and RUMEA in challenging markets. · Excellent growth and outperformance in Health. Strong innovation and sell-in offsetting tough comparatives. · Hygiene reduced by strong Dettol / Lysol comparatives and planned trade de-stocking in Middle East. · RBP - total US market volume film share 64% - excellent result. Strategic review progressing well. Capital markets solution is emerging as a strong option. · Strong foreign exchange headwind of -9%, as signaled with full year numbers. | skinny | |
12/4/2014 12:54 | Trading statement wednesday 16th april 14. | spacecake | |
03/4/2014 09:54 | 03 Apr 2014 Reckitt Benckiser... RB. Credit Suisse Outperform 4,849.00 4,855.00 5,200.00 5,200.00 03 Apr 2014 Reckitt Benckiser... RB. Citigroup Buy 4,849.00 4,855.00 5,400.00 5,400.00 | miata | |
11/3/2014 23:10 | Bank of America Merryll Lynch today reiterated buy and raised price target from £52.50 to £56.00. Hope this helps. | batman9 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions